Acetylcysteine Injection, Solution
Product Images NDC 70594-111

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetylcysteine (NDC 70594-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Acetylcysteine 01)

A line graph showing plasma acetaminophen concentrations (µg/mL) over time in hours post ingestion. The graph includes a solid reference line indicating toxicity risk threshold and annotations describing concentration intervals related to hepatotoxicity risk.*

FDA Label Image

Chemical Structure (Acetylcysteine 02)

Chemical structure of acetylcysteine showing its molecular components, including a methyl group, an amide nitrogen, a carboxyl group, and a thiol group.*

FDA Label Image

Principal Display Panel (30 mL Vial Carton)

Packaging label for Acetylcysteine Injection 6 g/30 mL (200 mg/mL) solution for intravenous injection. The label indicates 4 x 30 mL sterile single-dose vials requiring further dilution prior to use. Manufactured by Stelis Biopharma Limited, distributed by Xellia Pharmaceuticals USA LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.